FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to laboratory diagnostics, and can be used for early detection of infection-caused placental insufficiency (PI) development. To implement the method, the patient's biological fluids are analysed, including blood serum or cervical canal mucus to determine neopterin content. In case neopterin concentration exceeds 9 nmol/l in blood serum or 2 nmol/l in cervical canal mucus, placental insufficiency development is predicted women of high-risk groups with markers of urinogenital infections.
EFFECT: placental insufficiency at early pre-clinical stage of disease that enables timely medical and preventive measures that finally yields in favourable perinatal outcomes and reduced disease of newborns.
2 cl, 1 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PLACENTAL INSUFFICIENCY IN SECOND TRIMESTER OF PREGNANCY | 2014 |
|
RU2554827C1 |
| METHOD OF PREDICTING DEVELOPMENT OF PLACENTAL INSUFFICIENCY IN SECOND HALF OF PREGNANCY IN WOMEN WITH THREAT OF MISCARRIAGE AT EARLY TERMS OF INFECTION GENESIS | 2014 |
|
RU2558795C1 |
| METHOD FOR PREDICTING THE RISK OF PREGNANCY DISCONTINUITY AT UROGENITAL INFECTION | 2004 |
|
RU2281504C2 |
| METHOD FOR PREDICTION OF MISCARRIAGE OF INFECTIOUS GENESIS AT EARLY STAGES OF GESTATION | 2016 |
|
RU2627472C1 |
| METHOD FOR PREDICTION OF EARLY INFECTIOUS MISCARRIAGE | 2010 |
|
RU2444734C1 |
| METHOD FOR PREDICTING CEREBRAL DISORDERS IN NEONATALS IN MOTHERS FROM HIGH-RISK GROUP | 2005 |
|
RU2290644C1 |
| METHOD FOR PREDICTION OF EARLY MISCARRIAGE | 2012 |
|
RU2501017C1 |
| METHOD FOR PREDICTING THE THREAT OF EARLY TERMS MISCARRIAGE IN CASE OF CYTOMEGALOVIRUS INFECTION BY DETERMINING THE PLACENTAL GROWTH FACTOR IN BLOOD | 2017 |
|
RU2664446C1 |
| METHOD FOR PREDICTION OF THREATENED MISCARRIAGE IN 1 TRIMESTER | 2011 |
|
RU2469331C1 |
| METHOD OF PREDICTING OF MISCARRIAGE IN SECOND TRIMESTER OF PREGNANCY | 2007 |
|
RU2340899C1 |
